Nephroprotective effects of enalapril after (177Lu)-DOTATATE therapy using serial renal scintigraphies in a murine model of radiation-induced nephropathy
Radiation-induced nephropathy is still dose limiting in radionuclide therapy of neuroendocrine tumors. We investigated the nephroprotective potential of the angiotensine converting enzyme inhibiting drug enalpril after [177Lu]-DOTATATE therapy in a murine model of radiation-induced nephropathy by re...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
11 August 2016
|
| In: |
EJNMMI Research
Year: 2016, Volume: 6 |
| ISSN: | 2191-219X |
| DOI: | 10.1186/s13550-016-0219-2 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s13550-016-0219-2 |
| Author Notes: | Harun Ilhan, Hao Wang, Franz J. Gildehaus, Carmen Wängler, Tanja Herrler, Andrei Todica, Julia Schlichtiger, Paul Cumming, Peter Bartenstein, Marcus Hacker and Alexander R. Haug |
| Summary: | Radiation-induced nephropathy is still dose limiting in radionuclide therapy of neuroendocrine tumors. We investigated the nephroprotective potential of the angiotensine converting enzyme inhibiting drug enalpril after [177Lu]-DOTATATE therapy in a murine model of radiation-induced nephropathy by renal scintigraphy. |
|---|---|
| Item Description: | Im Titel ist der Ausdruck "177Lu" eckig geklammert Gesehen am 30.04.2020 |
| Physical Description: | Online Resource |
| ISSN: | 2191-219X |
| DOI: | 10.1186/s13550-016-0219-2 |